Buprenorphine infrequently found in fatal overdose in New York City

D. PAONE ; E. TUAZON ; M. STAJIC ; B. SAMPSON ; B. ALLEN ; S. MANTHA ; H. KUNINS | 2015
Dans Drug and Alcohol Dependence (Vol.155, October 2015) Article : Périodique

Background: Buprenorphine is an opioid agonist medication that is both safe and effective in the treatment of opioid use disorders and the prevention of opioid overdoses. Despite this, media coverage has highlighted public concerns about the pot[...]

Plus d'info

Ajouter à la sélection

Circumstances and contexts of heroin initiation following non-medical opioid analgesic use in New York City

A. HAROCOPOS ; B. ALLEN ; D. PAONE | 2016
Dans International Journal of Drug Policy (Vol.28, February 2016) Article : Périodique

Background: As the prevalence of opioid analgesic (OA) misuse and associated harms have increased in the United States, the prevalence of heroin use and rates of unintentional overdose have concurrently risen. Research has begun to identify conn[...]

Plus d'info

Ajouter à la sélection

Ontario treatment system research 1979-1993 : what have we learned about assessment and referral services in terms of the original expectations ?

B. RUSH ; K. ELLIS ; B. ALLEN ; K. GRAHAM | 1995
Périodique

FRANÇAIS : Le développement des centres d'évaluation et d'orientation s'est fait à partir d'un certain nombre d'attentes par rapport à leur possible influence sur l'évolution du système de soins. Les informations sur l'impact des centres sur le[...]

Plus d'info

Ajouter à la sélection

Nouveauté

A public health approach to increased synthetic cannabinoid-related morbidity among New York City residents, 2014-2015 [Viewpoint]

M. L. NOLAN ; B. ALLEN ; H. V. KUNINS ; D. PAONE | 2016
Dans International Journal of Drug Policy (Vol.34, August 2016) Article : Périodique

Despite continued prohibition of most drugs for recreational use, drug use is common in the United States. In 2013, nearly half of adults aged 12 years and older reported lifetime use of illicit drugs (47%), with 44% reporting lifetime cannabis [...]

Plus d'info

Ajouter à la sélection